Treatment of Histoplasmosis With Fluconazole in Patients With Acquired Immunodeficiency Syndromefn1fn1This study has been funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, under Contract Numbers: NO1-AI-15082 and NO1-AI-65296; the AIDS Clinical Trials Group and the Mycoses Study Group (Contract Numbers NO1-AI-15082 and NO1-AI-65296) of the National Institute of Allergy and Infectious Diseases; National Institutes of Health General Clinical Research Centers (Contract Numbers Mo1-RR00750-M01-RR02558); and Pfizer Central Research.fn2fn2The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the Unites States government.